| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/11/1999 | WO1999057289A2 INHIBIN-HBc FUSION PROTEIN |
| 11/11/1999 | WO1999057288A1 Endothelin-converting-enzyme like protein |
| 11/11/1999 | WO1999057286A1 Putative lactamase proteins from mouse and human |
| 11/11/1999 | WO1999057283A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 11/11/1999 | WO1999057281A2 Peptide antibiotics which inhibit the growth of pneumococci, abc transporter and two-component signal transduction system proteins from streptococcus pneumoniae, and methods using the same |
| 11/11/1999 | WO1999057280A2 Neisseria meningitidis antigens and compositions |
| 11/11/1999 | WO1999057278A2 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI) |
| 11/11/1999 | WO1999057275A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate |
| 11/11/1999 | WO1999057274A1 Human protease associated proteins |
| 11/11/1999 | WO1999057272A1 Peptide inhibitors of hiv replication |
| 11/11/1999 | WO1999057271A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 11/11/1999 | WO1999057270A2 Human receptor molecules |
| 11/11/1999 | WO1999057266A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 11/11/1999 | WO1999057265A1 Chimeric decoy rnas having synergistic anti-hiv activity |
| 11/11/1999 | WO1999057261A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
| 11/11/1999 | WO1999057251A2 Thrombolytic agents derived from streptokinase |
| 11/11/1999 | WO1999057244A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 11/11/1999 | WO1999057241A2 Myelin basic protein peptides and uses thereof |
| 11/11/1999 | WO1999057153A1 Heparanase specific molecular probes and their use in research and medical applications |
| 11/11/1999 | WO1999057151A2 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY |
| 11/11/1999 | WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 11/11/1999 | WO1999057148A1 Melanocortin 1 receptor selective compounds |
| 11/11/1999 | WO1999057147A1 Human thrombopoietin mutants |
| 11/11/1999 | WO1999057146A1 Protein mixtures to induce therapeutic angiogenesis |
| 11/11/1999 | WO1999057144A2 Human transcriptional regulator molecules |
| 11/11/1999 | WO1999057140A2 Growth-associated protease inhibitor heavy chain precursor |
| 11/11/1999 | WO1999057139A2 Pth2 receptor selective compounds |
| 11/11/1999 | WO1999057138A1 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppresssant and methods of use thereof |
| 11/11/1999 | WO1999057135A1 Antipicornaviral compounds, their preparation and use |
| 11/11/1999 | WO1999057134A1 Protein purification by ion exchange chromatography |
| 11/11/1999 | WO1999057133A2 Inhibitors of nf-kb activation |
| 11/11/1999 | WO1999057132A1 Secreted proteins and polynucleotides encoding them |
| 11/11/1999 | WO1999056797A1 Fully recombinant tissue sealant compositions |
| 11/11/1999 | WO1999056785A2 Cell mediated gene delivery using muscle derived cells for treating muscle-and bone-related injury or dysfunction |
| 11/11/1999 | WO1999056784A2 Inprovements in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10 |
| 11/11/1999 | WO1999056783A1 Hydrogel for the therapeutic treatment of aneurysms |
| 11/11/1999 | WO1999056778A1 The cytokine family member, 2-19 |
| 11/11/1999 | WO1999056777A1 REVERSAL OF PROINFLAMMATORY RESPONSE BY LIGATING THE MACROPHAGE FcηRI RECEPTOR |
| 11/11/1999 | WO1999056770A2 Novel therapy for treatment of lysosomal storage disease |
| 11/11/1999 | WO1999056769A2 Inhibition of helicobacter pylori proliferation |
| 11/11/1999 | WO1999056768A1 Methods for treating diabetes by inhibiting gdf-8 |
| 11/11/1999 | WO1999056767A2 Method for treating cytokine mediated hepatic injury |
| 11/11/1999 | WO1999056766A2 Method for treating ischemia |
| 11/11/1999 | WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 11/11/1999 | WO1999056764A1 Method for preventing or treating a human immunodeficiency virus infection |
| 11/11/1999 | WO1999056763A1 Use of neglected target tissue antigens in modulation of immune responses |
| 11/11/1999 | WO1999056762A1 Preventives and ameliorating agents for periodontosis |
| 11/11/1999 | WO1999056761A1 Methods for treatment of pain |
| 11/11/1999 | WO1999056760A1 N1-modified glycopeptides |
| 11/11/1999 | WO1999056758A1 A food composition and method of using same |
| 11/11/1999 | WO1999056755A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 11/11/1999 | WO1999056753A1 Hematopoietic stimulation |
| 11/11/1999 | WO1999056733A1 Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation |
| 11/11/1999 | WO1999056726A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 11/11/1999 | WO1999056725A1 Pharmaceutical compositions capable of being gelled |
| 11/11/1999 | WO1999056723A2 Hemoglobine-haptoglobin complexes for targeted drug delivery |
| 11/11/1999 | WO1999056700A2 Avian polyomavirus vaccines in psittacine birds |
| 11/11/1999 | WO1999056697A2 Pharmaceutical composition |
| 11/11/1999 | WO1999048348A8 Helicobacter pylori derived factor which inhibits ena-78 secretion |
| 11/11/1999 | WO1999047677A3 Polypeptides homologous to vegf and bmp1 |
| 11/11/1999 | WO1999047563A3 Ribonucleotide polypeptides containing metal |
| 11/11/1999 | WO1999047097A3 Material composition for the formation of tissue |
| 11/11/1999 | WO1999043791A9 Diisopropyl fluorophosphatase and the utilization and production thereof |
| 11/11/1999 | WO1999042574B1 Sequences of an ih ionic channel and the use thereof |
| 11/11/1999 | WO1999037778A3 Compositions and methods for detecting and treating prostate cancer |
| 11/11/1999 | WO1999035169A9 Methods and compositions for treating and diagnosing insulin related disorders |
| 11/11/1999 | WO1999030736A3 Methods to treat undesirable immune responses |
| 11/11/1999 | WO1999029863A9 Human interferon-epsilon: a type i interferon |
| 11/11/1999 | WO1999022773B1 Sequences for targeting metastatic cells |
| 11/11/1999 | DE19819273A1 Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung Ciclosporin pharmaceutical formulation with improved biopharmaceutical properties, increased physical stability and quality as well as process for preparing |
| 11/11/1999 | DE19805815C1 Diagnostikum zum Erkennen der autoimmunen Hepatitis Diagnostic tool for the detection of autoimmune hepatitis |
| 11/11/1999 | CA2650642A1 Neisseria meningitidis antigens and compositions |
| 11/11/1999 | CA2331844A1 A method for diagnosing and treating chronic pelvic pain syndrome |
| 11/11/1999 | CA2331607A1 Reversal of proinflammatory response by ligating the macrophage fc.gamma.ri receptor |
| 11/11/1999 | CA2331122A1 Hematopoietic stimulation |
| 11/11/1999 | CA2330838A1 Neisseria meningitidis antigens and compositions |
| 11/11/1999 | CA2330665A1 Protein mixtures to induce therapeutic angiogenesis |
| 11/11/1999 | CA2330619A1 N1-modified glycopeptides |
| 11/11/1999 | CA2329142A1 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
| 11/11/1999 | CA2328602A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| 11/11/1999 | CA2328483A1 Inhibitors of nf-kb activation |
| 11/11/1999 | CA2328132A1 Growth-associated protease inhibitor heavy chain precursor |
| 11/11/1999 | CA2328112A1 Methods for diagnosing and evaluating cancer |
| 11/11/1999 | CA2328108A1 Use of neglected target tissue antigens in modulation of immune responses |
| 11/11/1999 | CA2327550A1 Melanocortin 1 receptor selective compounds |
| 11/11/1999 | CA2327539A1 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 11/11/1999 | CA2327530A1 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 11/11/1999 | CA2327526A1 Thrombolytic agents derived from streptokinase |
| 11/11/1999 | CA2327509A1 Pth2 receptor selective compounds |
| 11/11/1999 | CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme |
| 11/11/1999 | CA2327457A1 Secreted proteins and polynucleotides encoding them |
| 11/11/1999 | CA2327355A1 Human receptor molecules |
| 11/11/1999 | CA2327263A1 Human protease associated proteins |
| 11/11/1999 | CA2327259A1 Human transcriptional regulator molecules |
| 11/11/1999 | CA2326763A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and methods for their synthesis |
| 11/11/1999 | CA2326671A1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 11/11/1999 | CA2326402A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 11/11/1999 | CA2326065A1 Method for treating cytokine mediated hepatic injury |
| 11/11/1999 | CA2325387A1 Method for treating ischemia |
| 11/11/1999 | CA2324650A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate |